World Journal of AIDS

Volume 4, Issue 4 (December 2014)

ISSN Print: 2160-8814   ISSN Online: 2160-8822

Google-based Impact Factor: 0.22  Citations  

Diversity of Human Immunodeficiency Virus Type-1 Subtypes in Western Kenya

HTML  XML Download Download as PDF (Size: 2564KB)  PP. 365-372  
DOI: 10.4236/wja.2014.44043    3,812 Downloads   4,830 Views  Citations

ABSTRACT

Background: HIV/AIDS is the principal pandemic in the world today. Two viral types (HIV-1 and HIV-2), with numerous groups (M, N and O for HIV-1 and A through H for HIV-2) have emerged. These have further proliferated into numerous subtypes, sub-subtypes and circulating recombinant forms (CRF) over the last 30 years. HIV-1 variants circulate together within a geographical region providing an opportunity for recombination of viral strains within infected individuals. In Kenya, at least nine different genetic HIV-1 subtypes and several recombinant forms have been defined within group M, which accounts for the majority of cases in the AIDS pandemic. Objective: To determine the genetic diversity of HIV-1 in the western region of Kenya bordering Uganda. Methodology: A cross sectional study was carried out at Busia District Hospital between 2007 and 2009. A total of 75 patients were sampled randomly from a cohort of 1000 clients on antiretroviral therapy. Blood samples were analysed at the HIV Laboratory, Kenya Medical Research Institute, Nairobi, Kenya. PCR was carried out on the Pol region of HIV, sequenced and analysed by BLAST for subtypes. Results: BLAST analysis revealed the following circulating subtypes: 40/75 (53.30%) were HIV-1 group M subtype A1; 21/75 (28.0%) were subtype D; 5/75 (6.7%) were subtype G; 4/75 (5.30%) were subtype C; and 2/75 (2.70%) were subtype A2. Only one isolate was identified for the other subtypes viz: 1/75 (1.30%) resembled subtype B; 1/75 (1.30%) was A1/C, and 1/75 (1.30%) was A1/D. Conclusion: The study showed increasing HIV-1 diversity along the Kenya-Uganda border with the emergence of A1/C and A1/D recombinants. Such HIV-1 diversityvis a vis the recent expanded access to antiretroviral therapy in resource limited settings calls for continuous evaluation of anti-HIV regimens. There is need therefore, for regular surveillance and monitoring for mutations that are likely to lead to drug resistance if we have to achieve successful treatment outcomes.

Share and Cite:

Adungo, F. , Gicheru, M. , Adungo, N. , Matilu, M. , Lihana, R. and Khamadi, S. (2014) Diversity of Human Immunodeficiency Virus Type-1 Subtypes in Western Kenya. World Journal of AIDS, 4, 365-372. doi: 10.4236/wja.2014.44043.

Cited by

[1] PROFILING NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR DRUG-RESISTANCE AND SUSCEPTIBILITY PATTERNS OF NAIVE HIV POSITIVE PATIENTS …
2022
[2] Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross-sectional study conducted in Teso …
2021
[3] Human immunodeficiency virus type 1 (HIV-1) subtype diversity in Busia, Western Kenya
African Journal of …, 2021
[4] Role of the Matrix-Capsid Cleavage Site Polymorphism S124V of HIV-1 Sub-subtype A2 in Gag Polyprotein Processing
2020
[5] Aspects of primary HIV-1 infection in New South Wales
2019
[6] HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia
2018
[7] Genetic characterization of antiretroviral resistance and their effect on human immunodeficiency virus infected patients initiating therapy in Kisumu-Kenya
2017
[8] Evaluation of Point-Of-Care Test for Early Infant Diagnosis and Viral Load Monitoring of Hiv-1 Infection in Western Kenya
2015
[9] HIV-1 Genetic Diversity in the Republic of Congo: Seventeen Years in Review
2015

Journals Menu
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.